Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$649M |
| 2 |
Nike
NKE
|
+$453M |
| 3 |
Tesla
TSLA
|
+$431M |
| 4 |
AstraZeneca
AZN
|
+$389M |
| 5 |
Coca-Cola
KO
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$897M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$578M |
| 3 |
Moderna
MRNA
|
+$438M |
| 4 |
Apple
AAPL
|
+$417M |
| 5 |
Aon
AON
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.55% |
| 2 | Technology | 20.49% |
| 3 | Consumer Staples | 11.15% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
2026
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.17M | ﹤0.01% |
85,361
+34,681
| +68% | +$1.02M |
|
2027
Coastal Financial
CCB
$802M
| $2.17M | ﹤0.01% |
68,174
+8,700
| +15% | +$259K |
|
2028
Silicom
SILC
$285M
| $2.17M | ﹤0.01% |
50,200
-21,600
| -30% | -$932K |
|
2029
Gogo Inc
GOGO
$383M
| $2.17M | ﹤0.01% |
125,368
+103,934
| +485% | +$1.26M |
|
|
JBGS
2030
JBG SMITH
JBGS
$672M
| $2.17M | ﹤0.01% |
73,200
-249,700
| -77% | -$7.71M |
|
|
TEN
2031
Tsakos Energy Navigation Ltd
TEN
$1.25B
| $2.17M | ﹤0.01% |
202,380
-153,215
| -43% | -$1.21M |
|
|
SMTS
2032
DELISTED
Sierra Metals Inc. Common Stock
SMTS
| $2.16M | ﹤0.01% |
1,201,172
-47,728
| -4% | -$118K |
|
2033
Pulmatrix
PULM
$5.62M
| $2.15M | ﹤0.01% |
134,658
-7,762
| -5% | -$130K |
|
2034
Vanguard FTSE Pacific ETF
VPL
$8.64B
| $2.15M | ﹤0.01% |
26,500
+6,600
| +33% | +$544K |
|
2035
APA Corp
APA
$14.2B
| $2.15M | ﹤0.01% |
100,116
-1,685,938
| -94% | -$32.2M |
|
2036
Eversource Energy
ES
$27.2B
| $2.14M | ﹤0.01% |
26,200
-16,180
| -38% | -$1.4M |
|
2037
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$12B
| $2.14M | ﹤0.01% |
16,000
-1,000
| -6% | -$138K |
|
|
KYNB
2038
Kyntra Bio
KYNB
$28.5M
| $2.13M | ﹤0.01% |
+8,346
| New | +$2.96M |
|
2039
Lisata Therapeutics
LSTA
$9.82M
| $2.13M | ﹤0.01% |
116,470
+12,281
| +12% | +$241K |
|
2040
Cocrystal Pharma
COCP
$15.4M
| $2.13M | ﹤0.01% |
168,897
-47,264
| -22% | -$625K |
|
2041
Cohu
COHU
$2.81B
| $2.12M | ﹤0.01% |
66,354
+24,030
| +57% | +$818K |
|
2042
Heritage Insurance Holdings
HRTG
$1.01B
| $2.12M | ﹤0.01% |
310,731
-55,068
| -15% | -$396K |
|
2043
Northern Technologies International Corp
NTIC
$75.9M
| $2.11M | ﹤0.01% |
138,977
-6,100
| -4% | -$109K |
|
2044
First United
FUNC
$293M
| $2.11M | ﹤0.01% |
113,495
-25,000
| -18% | -$444K |
|
2045
Tractor Supply
TSCO
$18.7B
| $2.11M | ﹤0.01% |
52,000
-930,000
| -95% | -$36.1M |
|
2046
Stoke Therapeutics
STOK
$2.02B
| $2.11M | ﹤0.01% |
82,800
+1,500
| +2% | +$41.8K |
|
2047
Verastem
VSTM
$596M
| $2.1M | ﹤0.01% |
56,933
+16,508
| +41% | +$606K |
|
2048
Alico
ALCO
$297M
| $2.1M | ﹤0.01% |
61,396
-23,700
| -28% | -$854K |
|
2049
Schwab US Mid-Cap ETF
SCHM
$15.4B
| $2.09M | ﹤0.01% |
81,900
+15,300
| +23% | +$400K |
|
2050
Coffee Holding Co
JVA
$20.2M
| $2.09M | ﹤0.01% |
459,744
+3,000
| +0.7% | +$15.3K |
|
Similar funds
Jim Simons's Q3 2021 Portfolio in Review
As of Q3 2021, Jim Simons held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Staples.
- Jim Simons's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
- Jim Simons added most to Nike in Q3 2021, an estimated $453M increase.
- Jim Simons's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
- Jim Simons fully exited Amazon in Q3 2021, selling an estimated $897M.
- Jim Simons's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
- Jim Simons opened 663 new positions and closed 653 in Q3 2021.
- Jim Simons's portfolio value fell 3.3% quarter-over-quarter to $77.4B.
Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.